Botanix Pharmaceuticals Limited (ASX:BOT)
0.1450
0.00 (0.00%)
Aug 21, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 284.36 million as of August 21, 2025. Its market cap has decreased by -50.13% in one year.
Market Cap
284.36M
Enterprise Value
236.79M
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 284.36M, an increase of 2,218.60%. That is a compound annual growth rate of 41.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 21, 2025 | 284.36M | -64.04% |
Dec 31, 2024 | 790.67M | 168.97% |
Dec 29, 2023 | 293.96M | 367.07% |
Dec 30, 2022 | 62.94M | 15.49% |
Dec 31, 2021 | 54.50M | -55.20% |
Dec 31, 2020 | 121.64M | 52.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 106.88B |
Pro Medicus | 32.13B |
Cochlear | 19.73B |
Sonic Healthcare | 14.20B |
Ramsay Health Care | 8.74B |
Telix Pharmaceuticals | 5.73B |
Ansell | 4.55B |
Mesoblast | 2.97B |